Achillion Pharmaceuticals, Inc. News Headlines

Get ACHN Alerts
*Delayed - data as of Feb. 26, 2015  -  Find a broker to begin trading ACHN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ACHN After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Hep C Franchise Will Remain Key Midterm Driver For Gilead
2/17/2015 1:34:00 PM - Seeking Alpha

Achillion Pharmaceuticals: A Strong Contender In A Crowded Space
2/17/2015 8:53:00 AM - Seeking Alpha

Achillion Pharmaceuticals: High Marketing Potential With Long-Term Prospects
2/14/2015 10:37:00 AM - Seeking Alpha

Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
2/13/2015 4:00:00 PM - Seeking Alpha

Achillion Prices Public Offering Of 12 Mln Common Shares At $10.25 Per Share
2/12/2015 12:07:00 AM - RTT News

Baxter Needs To Split Up - Cramer's Lightning Round (2/10/15)
2/11/2015 5:28:00 AM - Seeking Alpha

Jim Cramer Answers Twitter Questions on Coca-Cola, Yelp, Facebook, and More
2/9/2015 3:21:00 PM - TheStreet

Achillion Shares Rise, Regulus Falls After Hepatitis C Results
2/9/2015 1:55:00 PM - Dow Jones Business News

Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
2/9/2015 7:34:00 AM - Seeking Alpha

Stay Away From Martin Midstream - Cramer's Lightning Round (1/27/15)
1/28/2015 5:48:00 AM - Seeking Alpha

How To Play Gilead In 2015: It's Going To Be A Bumpy Ride
1/16/2015 1:45:00 PM - Seeking Alpha

I'm Expecting Some Very Positive News Flow From Gilead
1/12/2015 11:55:00 AM - Seeking Alpha

3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog
12/30/2014 10:41:00 AM - Investopedia

DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially
12/30/2014 7:05:00 AM - Seeking Alpha

Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More
12/26/2014 4:00:00 PM - Seeking Alpha

Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog
12/24/2014 9:48:00 AM - Investopedia

Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog
12/23/2014 5:00:00 AM - Investopedia

Stocks Turning In A Lackluster Performance In Mid-Day Trading - U.S. Commentary
12/22/2014 12:08:00 PM - RTT News

Today's Market: Hepatitis C News Moving These Stocks
12/22/2014 10:39:00 AM - Seeking Alpha

Stocks Move Modestly Higher, Extending Upward Trend - U.S. Commentary
12/22/2014 10:33:00 AM - RTT News

Sovaldi Can't Sustain The Current Prices Of Gilead Sciences' Stock: Algorithmic And Fundamental Analysis
12/12/2014 3:27:00 PM - Seeking Alpha

Achillion Pharmaceuticals To Present In Piper Jaffray Conference At 11:30 AM ET
12/3/2014 10:33:00 AM - RTT News

Achillion Pharma. To Present At Deutsche Bank BioFEST ; Webcast At 9:15 AM ET
12/1/2014 8:17:00 AM - RTT News

Regulus To See Further Declines
11/19/2014 12:21:00 PM - Seeking Alpha

Regulus To See Further Declines
11/19/2014 10:30:00 AM - Seeking Alpha